Search Results 541-550 of 16477 for immunothérapie vitiligo effets secondaires psychiatriques

  1. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  2. Early Onset and Hereditary GI Cancers Program - Clinical trials

    Mayo Clinic specialists offer advanced care for young people with colorectal, appendiceal, pancreatic, gastric, bile duct or other GI cancers.

  3. Study to Evaluate Chemoembolization Combined with Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma - Mayo Clinic

    The purpose of this global study is to evaluate transarterial chemoembolization (TACE) in combination with durvalumab and bevacizumab therapy in patients with ...

  4. Clinical trials - Oncology (Medical)

    This open-label, exploratory study is designed to evaluate the safety and efficacy of targeted therapies or immunotherapy as single agents or combinations ...

  5. Clinical trials - Oncology (Medical)

    The purpose of this study is to evaluate the association between a baseline comprehensive geriatric assessment (cGA) and chemotherapy toxicity in the first ...

  6. Autoimmune epilepsy - Symptoms and causes - Mayo Clinic

    Antiseizure medicines usually don't do enough to manage seizures in people with autoimmune epilepsy. Instead, immunotherapy medicines help reduce the immune ...

  7. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  8. Clinical trials - Oncology (Medical)

    The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

  9. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers publish key findings about cell proteins to determine effectiveness of immunotherapy for colon cancer. Kelley Luckstein.

  10. A Study to Evaluate Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant - Mayo Clinic

    A Study to Evaluate Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant · Overview · Participation ...